Compare IPEX & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IPEX | SEER |
|---|---|---|
| Founded | 2024 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 122.5M | 98.2M |
| IPO Year | 2025 | 2020 |
| Metric | IPEX | SEER |
|---|---|---|
| Price | $10.28 | $1.86 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 39.0K | ★ 165.8K |
| Earning Date | 04-15-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.25 | N/A |
| Revenue | N/A | ★ $16,376,999.00 |
| Revenue This Year | N/A | $22.37 |
| Revenue Next Year | N/A | $30.00 |
| P/E Ratio | $41.00 | ★ N/A |
| Revenue Growth | N/A | ★ 12.11 |
| 52 Week Low | $9.86 | $1.62 |
| 52 Week High | $10.40 | $2.50 |
| Indicator | IPEX | SEER |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 37.11 |
| Support Level | N/A | $1.77 |
| Resistance Level | N/A | $1.89 |
| Average True Range (ATR) | 0.00 | 0.08 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 0.00 | 30.00 |
Inflection Point Acquisition Corp V is a blank check company.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.